Mouse CD40 ligand-specific antibodies and hybridomas

Details Mouse CD40 ligand-specific antibodies and hybridomas Mouse CD40 ligand-specific antibodies and hybridomas

2007-12-18

2007-12-18

Gambel, Phillip (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S130100, C424S141100, C424S143100, C424S144100, C424S153100, C424S173100, C435S326000, C435S332000, C435S334000, C435S343000, C435S343200, C530S387100, C530S387900, C530S388100, C530S388220, C530S388700, C530S388730, C530S388750

Reexamination Certificate

active

09322021

ABSTRACT:
There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

REFERENCES:
patent: 5182368 (1993-01-01), Ledbetter
patent: 5247069 (1993-09-01), Ledbetter
patent: 5474771 (1995-12-01), Lederman
patent: 5876950 (1999-03-01), Siadak
patent: 5961974 (1999-10-01), Armitage et al.
patent: 0315062 (1989-05-01), None
patent: 0330191 (1989-08-01), None
patent: 0555880 (1993-08-01), None
patent: 0585943 (1994-03-01), None
patent: WO 93/09812 (1993-05-01), None
patent: WO 93/23550 (1993-11-01), None
6thInternational Workshop and Conference on Human Leukocyte Differentiation Antigens (Nov. 10-14, 1996) Kobe Japan, Proceedings, Fanslow et al, pp. 101-103.
6thInternational Workshop and Conference on Human Leukocyte Differentiation Antigens, Kobe Japan, Abstracts, vol. 48, No. 4—Part II, p. 477, TC-3-01 to TC-3-03 (Oct. 1996).
6thInternational Workshop and Conference on Human Leukocyte Differentiation Antigens, Kobe Japan, Abstract #381, Program TC-3-01, Armitage et al (Oct. 1996).
Casamayor-Palleja et al,J. Exp. Med., 181:1293-1302 (1995).
HLDA Antibody Database—Antibodies Assigned to CD154 (1998).
Aruffo et al,Proc. Natl. Acad. Sci., USA, 84:8573 (1987).
Stamenkovic et al,EMBO J., 8:1403 (1989).
Zettlmeissl et al,DNA Cell. Biol., 9:347 (1990).
Rousset et al,J. Exp. Med., 101:705 (1991).
Lederman et al,J. Exp. Med., 175:1091-1101 (1992).
Bancherau et al,Science, 251:70 (1991).
Banchereau et al,Clinical Immunology Spectrum, 3:9 (1991).
Liu et al,Nature, 342:929 (1989).
Ghaderi et al,Immunology, 73:510 (1991).
Kikutani et al,Cell, 47:657 (1986).
Wang et al,J. Virol., 65:4101 (1991).
Valle et al,Eur. J. Immunol., 19:1463 (1989).
Clark et al,Proc. Natl. Acad. Sci., USA, 83:4494 (1986).
Paulie t al,J. Immunol., 142:590 (1989).
Gordon et al,Eur. J. Immunol., 17:1535 (1987).
Jabara et al,J. Exp. Med., 172:1861 (1990).
Zhang et al,J. Immunol., 146:1836 (1991).
Gascan et al,J. Immunol., 147:8 (1991).
Gordon et al,J. Immunol., 140:1425 (1988).
Armitage et al,Nature, 357:80 (1992).
Fanslow et al,J. Immunol., 149:655 (1992).
Spriggs et al,J. Exp. Med., 176:1543 (1992).
Farrah et al,Nature, 358:26 (1992).
Noelle et al,Proc. Natl. Acad. Sci., USA, 89:6550 (1992).
Hollenbaugh et al,EMBO J., 11:4313 (1992).
Durie et al,Science, 261:1328 (1993).
Lauzon et al,Mol. Immunol., 25;829 (1988).

Affiliated with

Also associated with

Rating

Mouse CD40 ligand-specific antibodies and hybridomas does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mouse CD40 ligand-specific antibodies and hybridomas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mouse CD40 ligand-specific antibodies and hybridomas will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3827169